• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适配体偶联磁性纳米颗粒作为乳腺癌的靶向磁共振成像造影剂

Aptamer-conjugated Magnetic Nanoparticles as Targeted Magnetic Resonance Imaging Contrast Agent for Breast Cancer.

作者信息

Keshtkar Mohammad, Shahbazi-Gahrouei Daryoush, Khoshfetrat Seyyed Mehdi, Mehrgardi Masoud A, Aghaei Mahmoud

机构信息

Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Department of Chemistry, University of Isfahan, Isfahan 81746, Iran.

出版信息

J Med Signals Sens. 2016 Oct-Dec;6(4):243-247.

PMID:28028501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5157001/
Abstract

Early detection of breast cancer is the most effective way to improve the survival rate in women. Magnetic resonance imaging (MRI) offers high spatial resolution and good anatomic details, and its lower sensitivity can be improved by using targeted molecular imaging. In this study, AS1411 aptamer was conjugated to FeO@Au nanoparticles for specific targeting of mouse mammary carcinoma (4T1) cells that overexpress nucleolin. cytotoxicity of aptamer-conjugated nanoparticles was assessed on 4T1 and HFFF-PI6 (control) cells. The ability of the synthesized nanoprobe to target specifically the nucleolin overexpressed cells was assessed with the MRI technique. Results show that the synthesized nanoprobe produced strongly darkened T-weighted magnetic resonance (MR) images with 4T1 cells, whereas the MR images of HFFF-PI6 cells incubated with the nanoprobe are brighter, showing small changes compared to water. The results demonstrate that in a Fe concentration of 45 μg/mL, the nanoprobe reduced by 90% MR image intensity in 4T1 cells compared with the 27% reduction in HFFF-PI6 cells. Analysis of MR signal intensity showed statistically significant signal intensity difference between 4T1 and HFFF-PI6 cells treated with the nanoprobe. MRI experiments demonstrate the high potential of the synthesized nanoprobe as a specific MRI contrast agent for detection of nucleolin-expressing breast cancer cells.

摘要

早期发现乳腺癌是提高女性生存率的最有效方法。磁共振成像(MRI)具有高空间分辨率和良好的解剖细节,通过使用靶向分子成像可以提高其较低的灵敏度。在本研究中,AS1411适配体与FeO@Au纳米颗粒偶联,用于特异性靶向过表达核仁素的小鼠乳腺癌(4T1)细胞。评估了适配体偶联纳米颗粒对4T1和HFFF-PI6(对照)细胞的细胞毒性。用MRI技术评估了合成的纳米探针特异性靶向过表达核仁素细胞的能力。结果表明,合成的纳米探针在4T1细胞上产生了强烈变黑的T加权磁共振(MR)图像,而与纳米探针孵育的HFFF-PI6细胞的MR图像更亮,与水相比变化较小。结果表明,在铁浓度为45μg/mL时,纳米探针使4T1细胞的MR图像强度降低了90%,而HFFF-PI6细胞降低了27%。MR信号强度分析显示,用纳米探针处理的4T1和HFFF-PI6细胞之间的信号强度存在统计学显著差异。MRI实验证明了合成的纳米探针作为检测表达核仁素的乳腺癌细胞的特异性MRI造影剂具有很高的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63c/5157001/62b36527f7e1/JMSS-6-243-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63c/5157001/2ac933fbab90/JMSS-6-243-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63c/5157001/45efe823fb47/JMSS-6-243-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63c/5157001/30e6d60dbce5/JMSS-6-243-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63c/5157001/62b36527f7e1/JMSS-6-243-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63c/5157001/2ac933fbab90/JMSS-6-243-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63c/5157001/45efe823fb47/JMSS-6-243-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63c/5157001/30e6d60dbce5/JMSS-6-243-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63c/5157001/62b36527f7e1/JMSS-6-243-g004.jpg

相似文献

1
Aptamer-conjugated Magnetic Nanoparticles as Targeted Magnetic Resonance Imaging Contrast Agent for Breast Cancer.适配体偶联磁性纳米颗粒作为乳腺癌的靶向磁共振成像造影剂
J Med Signals Sens. 2016 Oct-Dec;6(4):243-247.
2
Multifunctional nanoprobe for cancer cell targeting and simultaneous fluorescence/magnetic resonance imaging.用于癌细胞靶向及同步荧光/磁共振成像的多功能纳米探针
Anal Chim Acta. 2016 Sep 28;938:156-64. doi: 10.1016/j.aca.2016.07.037. Epub 2016 Jul 28.
3
Assessment of Manganese-Zinc Ferrite Nanoparticles as a Novel Magnetic Resonance Imaging Contrast Agent for the Detection of 4T1 Breast Cancer Cells.评估锰锌铁氧体纳米颗粒作为检测4T1乳腺癌细胞的新型磁共振成像造影剂。
J Med Signals Sens. 2019 Oct 24;9(4):245-251. doi: 10.4103/jmss.JMSS_59_18. eCollection 2019 Oct-Dec.
4
A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer.一种基于核仁素靶向的多模态纳米颗粒成像探针,用于使用适体追踪癌细胞。
J Nucl Med. 2010 Jan;51(1):98-105. doi: 10.2967/jnumed.109.069880. Epub 2009 Dec 15.
5
Gadolinium oxide nanoparticles and aptamer-functionalized silver nanoclusters-based multimodal molecular imaging nanoprobe for optical/magnetic resonance cancer cell imaging.基于氧化钆纳米粒子和适配体功能化的银纳米簇的多模态分子成像纳米探针用于光学/磁共振癌细胞成像。
Anal Chem. 2014 Nov 18;86(22):11306-11. doi: 10.1021/ac503026d. Epub 2014 Nov 4.
6
Carbon Dots-AS1411 Aptamer Nanoconjugate for Ultrasensitive Spectrofluorometric Detection of Cancer Cells.碳点-AS1411 适体纳米复合物用于癌细胞的超灵敏光谱荧光检测。
Sci Rep. 2017 Sep 5;7(1):10513. doi: 10.1038/s41598-017-11087-2.
7
Improving sensitivity of magnetic resonance imaging by using a dual-targeted magnetic iron oxide nanoprobe.利用双靶向磁性氧化铁纳米探针提高磁共振成像的灵敏度。
Colloids Surf B Biointerfaces. 2018 Jan 1;161:339-346. doi: 10.1016/j.colsurfb.2017.10.059. Epub 2017 Oct 24.
8
Magnetic Iron Oxide Nanoparticles as T MR Imaging Contrast Agent for Detection of Breast Cancer (MCF-7) Cell.磁性氧化铁纳米颗粒作为用于检测乳腺癌(MCF-7)细胞的T磁共振成像造影剂
Avicenna J Med Biotechnol. 2017 Oct-Dec;9(4):181-188.
9
LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer.载 LyP-1 偶联纳米颗粒的三阴性乳腺癌磁共振成像研究。
Mol Imaging Biol. 2018 Jun;20(3):428-435. doi: 10.1007/s11307-017-1140-4.
10
In vitro Study of SPIONs-C595 as Molecular Imaging Probe for Specific Breast Cancer (MCF-7) Cells Detection.超顺磁性氧化铁纳米粒子- C595作为特异性乳腺癌(MCF-7)细胞检测分子成像探针的体外研究
Iran Biomed J. 2017 Nov;21(6):360-8. doi: 10.18869/acadpub.ibj.21.6.360. Epub 2017 Jun 11.

引用本文的文献

1
Tackling breast cancer with gold nanoparticles: twinning synthesis and particle engineering with efficacy.用金纳米颗粒攻克乳腺癌:孪晶合成与具有疗效的颗粒工程
Nanoscale Adv. 2024 Apr 17;6(11):2766-2812. doi: 10.1039/d3na00988b. eCollection 2024 May 29.
2
Formulation optimization of lyophilized aptamer-gold nanoparticles: Maintained colloidal stability and cellular uptake.冻干适体-金纳米颗粒的配方优化:维持胶体稳定性和细胞摄取。
Heliyon. 2024 May 8;10(10):e30743. doi: 10.1016/j.heliyon.2024.e30743. eCollection 2024 May 30.
3
FeO Magnetic Nanoparticles Obtained by the Novel Aerosol-Based Technique for Theranostic Applications.

本文引用的文献

1
Cobalt Zinc Ferrite Nanoparticles as a Potential Magnetic Resonance Imaging Agent: An In vitro Study.钴锌铁氧体纳米颗粒作为一种潜在的磁共振成像剂:一项体外研究。
Avicenna J Med Biotechnol. 2015 Apr-Jun;7(2):64-8.
2
Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.用(99m)Tc标记的AS1411适配体对前列腺肿瘤细胞进行肿瘤靶向。
J Drug Target. 2015;23(6):497-505. doi: 10.3109/1061186X.2015.1009075. Epub 2015 Feb 12.
3
Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI.
通过新型气溶胶技术制备的用于诊疗应用的FeO磁性纳米颗粒。
Materials (Basel). 2023 Sep 29;16(19):6483. doi: 10.3390/ma16196483.
4
Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach.靶向 HER2 乳腺癌的诊断与治疗:一种新方法。
Int J Mol Sci. 2021 Jun 7;22(11):6163. doi: 10.3390/ijms22116163.
5
Aptamer-Based In Vivo Therapeutic Targeting of Glioblastoma.基于适体的脑胶质瘤活体治疗靶向。
Molecules. 2020 Sep 17;25(18):4267. doi: 10.3390/molecules25184267.
6
Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents.适体作为诊断工具和治疗剂的当前观点。
Pharmaceutics. 2020 Jul 9;12(7):646. doi: 10.3390/pharmaceutics12070646.
7
Aptamers Increase Biocompatibility and Reduce the Toxicity of Magnetic Nanoparticles Used in Biomedicine.适配体可提高生物相容性并降低生物医学中使用的磁性纳米颗粒的毒性。
Biomedicines. 2020 Mar 14;8(3):59. doi: 10.3390/biomedicines8030059.
8
Assessment of Manganese-Zinc Ferrite Nanoparticles as a Novel Magnetic Resonance Imaging Contrast Agent for the Detection of 4T1 Breast Cancer Cells.评估锰锌铁氧体纳米颗粒作为检测4T1乳腺癌细胞的新型磁共振成像造影剂。
J Med Signals Sens. 2019 Oct 24;9(4):245-251. doi: 10.4103/jmss.JMSS_59_18. eCollection 2019 Oct-Dec.
9
Synthesis and Cytotoxicity Assessment of Gold-coated Magnetic Iron Oxide Nanoparticles.金包覆磁性氧化铁纳米颗粒的合成与细胞毒性评估
J Biomed Phys Eng. 2018 Dec 1;8(4):357-364. eCollection 2018 Dec.
10
Application of Different methods for Reducing Radiation Dose to Breast during MDCT.多层螺旋CT(MDCT)检查期间降低乳腺辐射剂量的不同方法应用
J Biomed Phys Eng. 2018 Dec 1;8(4):341-346. eCollection 2018 Dec.
蛙皮素-超顺磁性氧化铁纳米颗粒的合成与表征:一种用于乳腺癌MRI成像的靶向造影剂
Nanotechnology. 2015 Feb 20;26(7):075101. doi: 10.1088/0957-4484/26/7/075101. Epub 2015 Feb 2.
4
Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection.超顺磁性氧化铁-C595:用于检测卵巢癌的潜在磁共振成像造影剂。
J Med Phys. 2013 Oct;38(4):198-204. doi: 10.4103/0971-6203.121198.
5
Detection of MUC1-expressing ovarian cancer by C595 monoclonal antibody-conjugated SPIONs using MR imaging.使用磁共振成像通过C595单克隆抗体偶联的超顺磁性氧化铁纳米颗粒检测表达MUC1的卵巢癌。
ScientificWorldJournal. 2013 Sep 30;2013:609151. doi: 10.1155/2013/609151. eCollection 2013.
6
Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer.抗 HER2 抗体和 ScFvEGFR 偶联的抗污磁性氧化铁纳米颗粒用于乳腺癌的靶向和磁共振成像。
Int J Nanomedicine. 2013;8:3781-94. doi: 10.2147/IJN.S49069. Epub 2013 Oct 2.
7
Breast cancer statistics, 2013.乳腺癌统计数据,2013 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62. doi: 10.3322/caac.21203. Epub 2013 Oct 1.
8
Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging.适配体偶联的 Mn3O4@SiO2 核壳纳米探针用于靶向磁共振成像。
Nanoscale. 2013 Nov 7;5(21):10447-54. doi: 10.1039/c3nr03490a. Epub 2013 Sep 13.
9
Functionalized magnetic nanoparticles for the detection and quantitative analysis of cell surface antigen.功能化磁性纳米颗粒用于细胞表面抗原的检测和定量分析。
Biomed Res Int. 2013;2013:349408. doi: 10.1155/2013/349408. Epub 2012 Dec 31.
10
Comparative in vitro cytotoxicity study on uncoated magnetic nanoparticles: effects on cell viability, cell morphology, and cellular uptake.未包覆磁性纳米颗粒的体外细胞毒性比较研究:对细胞活力、细胞形态和细胞摄取的影响。
J Nanosci Nanotechnol. 2012 Dec;12(12):9010-7. doi: 10.1166/jnn.2012.6755.